Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06423729
PHASE2/PHASE3

Effect of Nicorandil in Type 2 Diabetic Obese Patients

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.

Official title: Clinical Study Evaluating the Effect of Nicorandil in Type 2 Diabetic Obese Patients Treated With Sulfonylurea

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

46

Start Date

2024-06-01

Completion Date

2025-01

Last Updated

2024-05-23

Healthy Volunteers

No

Interventions

DRUG

Nicorandil 10 MG

Patients will receive oral Nicorandil 10 MG twice daily in addition to 2nd generation sulfonylureas , for 3 months.

Locations (1)

Faculty of Pharmacy, Tanta University

Tanta, Egypt